Literature DB >> 23605437

Guest editorial: advances in the management of acquired aplastic anemia.

Shinji Nakao.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23605437     DOI： 10.1007/s12185-013-1325-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  4 in total

1.  Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.

Authors:  Takehiko Mori; Hideo Koh; Yasushi Onishi; Shinichi Kako; Makoto Onizuka; Heiwa Kanamori; Yukiyasu Ozawa; Chiaki Kato; Hiroatsu Iida; Ritsuro Suzuki; Tatsuo Ichinohe; Yoshinobu Kanda; Tetsuo Maeda; Shinji Nakao; Hirohito Yamazaki
Journal:  Int J Hematol       Date:  2016-02-24       Impact factor: 2.490

2.  Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia.

Authors:  Sumiko Kohashi; Takehiko Mori; Risa Hashida; Jun Kato; Masuho Saburi; Taku Kikuchi; Yuya Koda; Takaaki Toyama; Yusuke Yamane; Satomi Yamanaka; Shinichiro Okamoto
Journal:  Int J Hematol       Date:  2014-11-09       Impact factor: 2.490

Review 3.  Microbe-Induced Inflammatory Signals Triggering Acquired Bone Marrow Failure Syndromes.

Authors:  J Luis Espinoza; Ritesh Kotecha; Shinji Nakao
Journal:  Front Immunol       Date:  2017-02-24       Impact factor: 7.561

4.  Effects of Shikonin on the Functions of Myeloid Dendritic Cells in a Mouse Model of Severe Aplastic Anemia.

Authors:  Mengying Zheng; Bingnan Liu; Yuanyuan Shao; Luogang Hua; Rong Fu; Huaquan Wang; Ting Wang; Weiwei Qi; Zonghong Shao; Chunyan Liu
Journal:  Mediators Inflamm       Date:  2020-02-20       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.